Browse > Article
http://dx.doi.org/10.3345/kjp.2010.53.4.571

Efficacy of levetiracetam in refractory childhood epilepsy  

Lee, Keon-Su (Institute for Brain Research, Chungnam National University, Department of Pediatrics, College of Medicine, Chungnam National University)
Kang, Joon-Won (Institute for Brain Research, Chungnam National University, Department of Pediatrics, College of Medicine, Chungnam National University)
Publication Information
Clinical and Experimental Pediatrics / v.53, no.4, 2010 , pp. 571-578 More about this Journal
Abstract
Purpose : To evaluate the efficacy and safety of levetiracetam adjunctive therapy for reducing the rate of seizure frequency in children with intractable pediatric epilepsy. Methods : We reviewed the medical records of 86 patients with intractable pediatric epilepsy who visited our hospital between March 1989 and February 2009. Levetiracetam was included in the previous anticonvulsant regimen for at least 6 months and the reduction in the rate of seizure frequency was determined in follow-up examinations. We analyzed demographic data, seizure types, antiepileptic drug history, levetiracetam dose, adverse effects of levetiracetam therapy, treatment outcome, electroencephalogram findings, etc. Results : More than 50% reduction in the seizure frequency was observed in 62 of the 86 (72.1%) patients; 44 patients (51.1%) became seizure free, while the seizure frequency increased in 5.8% patients. The associations between seizure reduction rate and age, associated diseases, seizure types, and seizure frequency before treatment were not significant. However, the duration of disease, dose of levetiracetam, duration and frequency of anticonvulsant administration before levetiracetam therapy were significantly correlated. Electroencephalogram findings and the cause of epilepsy showed partial correlation. Forty (46%) patients showed adverse symptoms; the symptoms in the order of their frequency were somnolence, hyperactivity, irritability, aggressiveness, tiredness, etc. Conclusion : The findings of our study provide the evidence that levetiracetam adjunctive therapy is efficacious and well tolerated in various refractory childhood epilepsy cases.
Keywords
Levetiracetam; Intractable epilepsy; Child;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Coppola G, Mangano S, Tortorella G, Pelliccia A, Fels A, Romano A, et al. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Epilepsy Res 2004;59:35-42.   DOI   ScienceOn
2 Shorvon SD. Medical assesment and treatment of chronic epilepsy. BMJ 1991;302:363-6.   DOI   ScienceOn
3 Vigevano F. Levetiracetam in pediatrics. J Child Neurol 2005; 20:87-93.   DOI   ScienceOn
4 Lynch BA, Lambeng N, Nocka K. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004;101:9861-6.   DOI   ScienceOn
5 Otoul C, Smedt HD, Stockis A. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. Epilepsia 2007;48:2111-5.   DOI   ScienceOn
6 Perry MS, Benatar M. Efficacy and tolerability of levetiracetam in children younger than 4 years: A retrospective review. Epilepsia 2007;48:1123-7.   DOI   ScienceOn
7 Striano P, Coppola A, Pezzella M, Ciampa C, Specchio N, Ragona F, et al. An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 2007;69:250- 4.   DOI   ScienceOn
8 Barron TF, Faircloth VC, Yuncker LA, Hunt SL. Levetiracetam adjunctive therapy for refractory pediatric generalized epilepsies. Epilepsia 2001;42(7 Suppl):S53.
9 Buyse G, Ceulemans B, Lagae L. Add-on levetiracetam on refractory generalized childhood epilepsy syndromes. Epilepsia 2002;43(8 Suppl):S154.   DOI   ScienceOn
10 Berg J, Wruk M, Baeumel C, Kluger G, Holthausen H. Addon therapy with levetiracetam in difficult-to-treat, idiopathic focal epilepsies of childhood. Epilepsia 2003;44(8 Suppl):S79.   DOI   ScienceOn
11 Mikati MA, Banna DEI, Sinno D, Mroueh S. Response of infantile spasms to levetiracetam. Neurology 2008;70:574-5.   DOI   ScienceOn
12 Pina-Garza JE, Nordli DR, Rating D, Yang H, Jimmy SD, Duncan B, et al. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia 2009;50:1141-9.   DOI   ScienceOn
13 Vaisleib II, Neft RA. Rapid dosge titration of levetiracetam in children. Pharmacotherapy 2008;28:393-6.   DOI   ScienceOn
14 Kossoff EH, Los JG, Boatman DF. A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy. Epilepsy & Behavior 2007;11:514-7.   DOI   ScienceOn
15 Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Glauer LJ, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006;66:1654-60.   DOI   ScienceOn
16 Grosso S, Cordelli DM, Franzoni E, Coppola G, Capovilla G, Zamponi N, et al. Efficacy and safty of levetiracetam in infants and young children with refractory epilepsy. Seizure 2007;16:345-50.   DOI   ScienceOn
17 Glauser TA, Pellock JM, Bebin EM. Efficacy and safty of levetiracetam in children with partial seizures: An open-lavel trial. Epilepsia 2002;43:518-24.   DOI   ScienceOn
18 Verrotti A, Cerminara C, Coppola G, Franzoni E, Parisi P, Iannetti P, et al. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Developmental medicine & child neurology 2008;50:29-32.
19 Goraya JS, Khurana DS, Valencia I, Melvin JJ, Cruz M, Legido A, et al. Intravenous levetiracetam in children with epilepsy. Pediatr Neurol 2008;38;177-80.   DOI   ScienceOn
20 Bourgeois BFD, Holder DL, Valencia I. Open-label assesment of levetiracetam efficacy and adverse effects in a pediatric population. Epilepsia 2001;42:53-4.
21 Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007;69:1751-60.
22 Radtke RA. Pharmacokinetics of levetiracetam. Epilepsia. 2001;42;24-7.
23 Opp J, Tuxhorn I, May T, Kluger G, Wiemer-Kruel A, Kurlemann G, et al. Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany. Seizure 2005;14:476-84.   DOI   ScienceOn
24 Park JS, Kang HC, You SJ. Clinical experience with levetiracetam adjunctive therapy for pediatric intractable epilepsy. J Korean Child Neurol Soc 2008;16:36-41.
25 Pellock JM, Glauser TA, Bebin EM. Pharmacokinetic study of levetiracetam in children. Epilepsia 2001;42:1574-9.
26 Glauser TA, Mitchell WG, Weinstock A, Bebin M, Chen D, Coupez R, et al. Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Epilepsia 2007;48:1117- 22.   DOI   ScienceOn
27 Berg AT, Kelly MM. Defining intractability: comparisons among published definitions. Epilepsia 2006;47:431-6.   DOI   ScienceOn
28 Lagae L, Buyse G, Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and monotherapy trial. Seizure 2005;14:66-71.   DOI   ScienceOn